0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Continuous Blood Glucose Monitoring Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-31L4092
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Continuous Blood Glucose Monitoring Market Insights and Forecast to 2028
BUY CHAPTERS

Global Continuous Blood Glucose Monitoring Market Research Report 2025

Code: QYRE-Auto-31L4092
Report
August 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Continuous Blood Glucose Monitoring Market

The global market for Continuous Blood Glucose Monitoring was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Continuous blood glucose monitoring system is a medical device which is used to track and monitor glucose levels in the blood. This system will help the patients to continuously track & monitor the fluctuations in the sugar level. The various components of continuous blood glucose monitoring system are insulin pumps, sensors, and transmitters and receivers among other to monitor it in real time.
North America region is expected to dominate the continuous blood glucose monitoring system market in the global arena due to growing FDA approvals and increase in number of diabetic patients in the US. However, rising economies of China & India and enhancing healthcare infrastructure in APAC is expected to boost the demand for continuous blood glucose monitoring system market in the future.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Continuous Blood Glucose Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Blood Glucose Monitoring.
The Continuous Blood Glucose Monitoring market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Continuous Blood Glucose Monitoring market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Blood Glucose Monitoring manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Continuous Blood Glucose Monitoring Market Report

Report Metric Details
Report Name Continuous Blood Glucose Monitoring Market
Segment by Type
  • Self-Monitoring Blood Glucose Systems
  • Continuous Glucose Monitoring Systems
Segment by Application
  • Hospitals
  • Clinics
  • Home Care
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Lifescan, Medtronic, Bayer AG, Abbott, Terumo, Dexcom, Echo Therapeutics, B. Braun Melsungen, Arkray, Cellnovo Group, Nemaura, Tandem Diabetes Care
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Continuous Blood Glucose Monitoring manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Continuous Blood Glucose Monitoring in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Continuous Blood Glucose Monitoring Market report?

Ans: The main players in the Continuous Blood Glucose Monitoring Market are Roche, Lifescan, Medtronic, Bayer AG, Abbott, Terumo, Dexcom, Echo Therapeutics, B. Braun Melsungen, Arkray, Cellnovo Group, Nemaura, Tandem Diabetes Care

What are the Application segmentation covered in the Continuous Blood Glucose Monitoring Market report?

Ans: The Applications covered in the Continuous Blood Glucose Monitoring Market report are Hospitals, Clinics, Home Care

What are the Type segmentation covered in the Continuous Blood Glucose Monitoring Market report?

Ans: The Types covered in the Continuous Blood Glucose Monitoring Market report are Self-Monitoring Blood Glucose Systems, Continuous Glucose Monitoring Systems

1 Continuous Blood Glucose Monitoring Market Overview
1.1 Product Definition
1.2 Continuous Blood Glucose Monitoring by Type
1.2.1 Global Continuous Blood Glucose Monitoring Market Value Comparison by Type (2024 VS 2031)
1.2.2 Self-Monitoring Blood Glucose Systems
1.2.3 Continuous Glucose Monitoring Systems
1.3 Continuous Blood Glucose Monitoring by Application
1.3.1 Global Continuous Blood Glucose Monitoring Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Global Continuous Blood Glucose Monitoring Market Size Estimates and Forecasts
1.4.1 Global Continuous Blood Glucose Monitoring Revenue 2020-2031
1.4.2 Global Continuous Blood Glucose Monitoring Sales 2020-2031
1.4.3 Global Continuous Blood Glucose Monitoring Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Continuous Blood Glucose Monitoring Market Competition by Manufacturers
2.1 Global Continuous Blood Glucose Monitoring Sales Market Share by Manufacturers (2020-2025)
2.2 Global Continuous Blood Glucose Monitoring Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Continuous Blood Glucose Monitoring Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Continuous Blood Glucose Monitoring, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Continuous Blood Glucose Monitoring, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Continuous Blood Glucose Monitoring, Product Type & Application
2.7 Global Key Manufacturers of Continuous Blood Glucose Monitoring, Date of Enter into This Industry
2.8 Global Continuous Blood Glucose Monitoring Market Competitive Situation and Trends
2.8.1 Global Continuous Blood Glucose Monitoring Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Continuous Blood Glucose Monitoring Players Market Share by Revenue
2.8.3 Global Continuous Blood Glucose Monitoring Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Continuous Blood Glucose Monitoring Market Scenario by Region
3.1 Global Continuous Blood Glucose Monitoring Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Continuous Blood Glucose Monitoring Sales by Region: 2020-2031
3.2.1 Global Continuous Blood Glucose Monitoring Sales by Region: 2020-2025
3.2.2 Global Continuous Blood Glucose Monitoring Sales by Region: 2026-2031
3.3 Global Continuous Blood Glucose Monitoring Revenue by Region: 2020-2031
3.3.1 Global Continuous Blood Glucose Monitoring Revenue by Region: 2020-2025
3.3.2 Global Continuous Blood Glucose Monitoring Revenue by Region: 2026-2031
3.4 North America Continuous Blood Glucose Monitoring Market Facts & Figures by Country
3.4.1 North America Continuous Blood Glucose Monitoring Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Continuous Blood Glucose Monitoring Sales by Country (2020-2031)
3.4.3 North America Continuous Blood Glucose Monitoring Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Continuous Blood Glucose Monitoring Market Facts & Figures by Country
3.5.1 Europe Continuous Blood Glucose Monitoring Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Continuous Blood Glucose Monitoring Sales by Country (2020-2031)
3.5.3 Europe Continuous Blood Glucose Monitoring Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Continuous Blood Glucose Monitoring Market Facts & Figures by Region
3.6.1 Asia Pacific Continuous Blood Glucose Monitoring Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Continuous Blood Glucose Monitoring Sales by Region (2020-2031)
3.6.3 Asia Pacific Continuous Blood Glucose Monitoring Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Continuous Blood Glucose Monitoring Market Facts & Figures by Country
3.7.1 Latin America Continuous Blood Glucose Monitoring Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Continuous Blood Glucose Monitoring Sales by Country (2020-2031)
3.7.3 Latin America Continuous Blood Glucose Monitoring Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Continuous Blood Glucose Monitoring Market Facts & Figures by Country
3.8.1 Middle East and Africa Continuous Blood Glucose Monitoring Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Continuous Blood Glucose Monitoring Sales by Country (2020-2031)
3.8.3 Middle East and Africa Continuous Blood Glucose Monitoring Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Continuous Blood Glucose Monitoring Sales by Type (2020-2031)
4.1.1 Global Continuous Blood Glucose Monitoring Sales by Type (2020-2025)
4.1.2 Global Continuous Blood Glucose Monitoring Sales by Type (2026-2031)
4.1.3 Global Continuous Blood Glucose Monitoring Sales Market Share by Type (2020-2031)
4.2 Global Continuous Blood Glucose Monitoring Revenue by Type (2020-2031)
4.2.1 Global Continuous Blood Glucose Monitoring Revenue by Type (2020-2025)
4.2.2 Global Continuous Blood Glucose Monitoring Revenue by Type (2026-2031)
4.2.3 Global Continuous Blood Glucose Monitoring Revenue Market Share by Type (2020-2031)
4.3 Global Continuous Blood Glucose Monitoring Price by Type (2020-2031)
5 Segment by Application
5.1 Global Continuous Blood Glucose Monitoring Sales by Application (2020-2031)
5.1.1 Global Continuous Blood Glucose Monitoring Sales by Application (2020-2025)
5.1.2 Global Continuous Blood Glucose Monitoring Sales by Application (2026-2031)
5.1.3 Global Continuous Blood Glucose Monitoring Sales Market Share by Application (2020-2031)
5.2 Global Continuous Blood Glucose Monitoring Revenue by Application (2020-2031)
5.2.1 Global Continuous Blood Glucose Monitoring Revenue by Application (2020-2025)
5.2.2 Global Continuous Blood Glucose Monitoring Revenue by Application (2026-2031)
5.2.3 Global Continuous Blood Glucose Monitoring Revenue Market Share by Application (2020-2031)
5.3 Global Continuous Blood Glucose Monitoring Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Continuous Blood Glucose Monitoring Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Lifescan
6.2.1 Lifescan Company Information
6.2.2 Lifescan Description and Business Overview
6.2.3 Lifescan Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Lifescan Continuous Blood Glucose Monitoring Product Portfolio
6.2.5 Lifescan Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Medtronic Continuous Blood Glucose Monitoring Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Bayer AG
6.4.1 Bayer AG Company Information
6.4.2 Bayer AG Description and Business Overview
6.4.3 Bayer AG Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer AG Continuous Blood Glucose Monitoring Product Portfolio
6.4.5 Bayer AG Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Company Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Abbott Continuous Blood Glucose Monitoring Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 Terumo
6.6.1 Terumo Company Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Terumo Continuous Blood Glucose Monitoring Product Portfolio
6.6.5 Terumo Recent Developments/Updates
6.7 Dexcom
6.7.1 Dexcom Company Information
6.7.2 Dexcom Description and Business Overview
6.7.3 Dexcom Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Dexcom Continuous Blood Glucose Monitoring Product Portfolio
6.7.5 Dexcom Recent Developments/Updates
6.8 Echo Therapeutics
6.8.1 Echo Therapeutics Company Information
6.8.2 Echo Therapeutics Description and Business Overview
6.8.3 Echo Therapeutics Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Echo Therapeutics Continuous Blood Glucose Monitoring Product Portfolio
6.8.5 Echo Therapeutics Recent Developments/Updates
6.9 B. Braun Melsungen
6.9.1 B. Braun Melsungen Company Information
6.9.2 B. Braun Melsungen Description and Business Overview
6.9.3 B. Braun Melsungen Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.9.4 B. Braun Melsungen Continuous Blood Glucose Monitoring Product Portfolio
6.9.5 B. Braun Melsungen Recent Developments/Updates
6.10 Arkray
6.10.1 Arkray Company Information
6.10.2 Arkray Description and Business Overview
6.10.3 Arkray Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Arkray Continuous Blood Glucose Monitoring Product Portfolio
6.10.5 Arkray Recent Developments/Updates
6.11 Cellnovo Group
6.11.1 Cellnovo Group Company Information
6.11.2 Cellnovo Group Description and Business Overview
6.11.3 Cellnovo Group Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Cellnovo Group Continuous Blood Glucose Monitoring Product Portfolio
6.11.5 Cellnovo Group Recent Developments/Updates
6.12 Nemaura
6.12.1 Nemaura Company Information
6.12.2 Nemaura Description and Business Overview
6.12.3 Nemaura Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Nemaura Continuous Blood Glucose Monitoring Product Portfolio
6.12.5 Nemaura Recent Developments/Updates
6.13 Tandem Diabetes Care
6.13.1 Tandem Diabetes Care Company Information
6.13.2 Tandem Diabetes Care Description and Business Overview
6.13.3 Tandem Diabetes Care Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Tandem Diabetes Care Continuous Blood Glucose Monitoring Product Portfolio
6.13.5 Tandem Diabetes Care Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Continuous Blood Glucose Monitoring Industry Chain Analysis
7.2 Continuous Blood Glucose Monitoring Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Continuous Blood Glucose Monitoring Production Mode & Process Analysis
7.4 Continuous Blood Glucose Monitoring Sales and Marketing
7.4.1 Continuous Blood Glucose Monitoring Sales Channels
7.4.2 Continuous Blood Glucose Monitoring Distributors
7.5 Continuous Blood Glucose Monitoring Customer Analysis
8 Continuous Blood Glucose Monitoring Market Dynamics
8.1 Continuous Blood Glucose Monitoring Industry Trends
8.2 Continuous Blood Glucose Monitoring Market Drivers
8.3 Continuous Blood Glucose Monitoring Market Challenges
8.4 Continuous Blood Glucose Monitoring Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Continuous Blood Glucose Monitoring Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Continuous Blood Glucose Monitoring Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Continuous Blood Glucose Monitoring Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Continuous Blood Glucose Monitoring Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Continuous Blood Glucose Monitoring Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Continuous Blood Glucose Monitoring Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Continuous Blood Glucose Monitoring Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Continuous Blood Glucose Monitoring Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Continuous Blood Glucose Monitoring, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Continuous Blood Glucose Monitoring, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Continuous Blood Glucose Monitoring, Product Type & Application
 Table 12. Global Key Manufacturers of Continuous Blood Glucose Monitoring, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Continuous Blood Glucose Monitoring by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Blood Glucose Monitoring as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Continuous Blood Glucose Monitoring Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Continuous Blood Glucose Monitoring Sales by Region (2020-2025) & (K Units)
 Table 18. Global Continuous Blood Glucose Monitoring Sales Market Share by Region (2020-2025)
 Table 19. Global Continuous Blood Glucose Monitoring Sales by Region (2026-2031) & (K Units)
 Table 20. Global Continuous Blood Glucose Monitoring Sales Market Share by Region (2026-2031)
 Table 21. Global Continuous Blood Glucose Monitoring Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Continuous Blood Glucose Monitoring Revenue Market Share by Region (2020-2025)
 Table 23. Global Continuous Blood Glucose Monitoring Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Continuous Blood Glucose Monitoring Revenue Market Share by Region (2026-2031)
 Table 25. North America Continuous Blood Glucose Monitoring Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Continuous Blood Glucose Monitoring Sales by Country (2020-2025) & (K Units)
 Table 27. North America Continuous Blood Glucose Monitoring Sales by Country (2026-2031) & (K Units)
 Table 28. North America Continuous Blood Glucose Monitoring Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Continuous Blood Glucose Monitoring Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Continuous Blood Glucose Monitoring Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Continuous Blood Glucose Monitoring Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Continuous Blood Glucose Monitoring Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Continuous Blood Glucose Monitoring Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Continuous Blood Glucose Monitoring Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Continuous Blood Glucose Monitoring Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Continuous Blood Glucose Monitoring Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Continuous Blood Glucose Monitoring Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Continuous Blood Glucose Monitoring Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Continuous Blood Glucose Monitoring Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Continuous Blood Glucose Monitoring Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Continuous Blood Glucose Monitoring Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Continuous Blood Glucose Monitoring Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Continuous Blood Glucose Monitoring Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Continuous Blood Glucose Monitoring Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Continuous Blood Glucose Monitoring Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Continuous Blood Glucose Monitoring Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Continuous Blood Glucose Monitoring Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Continuous Blood Glucose Monitoring Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Continuous Blood Glucose Monitoring Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Continuous Blood Glucose Monitoring Sales (K Units) by Type (2020-2025)
 Table 51. Global Continuous Blood Glucose Monitoring Sales (K Units) by Type (2026-2031)
 Table 52. Global Continuous Blood Glucose Monitoring Sales Market Share by Type (2020-2025)
 Table 53. Global Continuous Blood Glucose Monitoring Sales Market Share by Type (2026-2031)
 Table 54. Global Continuous Blood Glucose Monitoring Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Continuous Blood Glucose Monitoring Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Continuous Blood Glucose Monitoring Revenue Market Share by Type (2020-2025)
 Table 57. Global Continuous Blood Glucose Monitoring Revenue Market Share by Type (2026-2031)
 Table 58. Global Continuous Blood Glucose Monitoring Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Continuous Blood Glucose Monitoring Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Continuous Blood Glucose Monitoring Sales (K Units) by Application (2020-2025)
 Table 61. Global Continuous Blood Glucose Monitoring Sales (K Units) by Application (2026-2031)
 Table 62. Global Continuous Blood Glucose Monitoring Sales Market Share by Application (2020-2025)
 Table 63. Global Continuous Blood Glucose Monitoring Sales Market Share by Application (2026-2031)
 Table 64. Global Continuous Blood Glucose Monitoring Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Continuous Blood Glucose Monitoring Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Continuous Blood Glucose Monitoring Revenue Market Share by Application (2020-2025)
 Table 67. Global Continuous Blood Glucose Monitoring Revenue Market Share by Application (2026-2031)
 Table 68. Global Continuous Blood Glucose Monitoring Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Continuous Blood Glucose Monitoring Price (USD/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Continuous Blood Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Continuous Blood Glucose Monitoring Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Lifescan Company Information
 Table 76. Lifescan Description and Business Overview
 Table 77. Lifescan Continuous Blood Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Lifescan Continuous Blood Glucose Monitoring Product
 Table 79. Lifescan Recent Developments/Updates
 Table 80. Medtronic Company Information
 Table 81. Medtronic Description and Business Overview
 Table 82. Medtronic Continuous Blood Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Medtronic Continuous Blood Glucose Monitoring Product
 Table 84. Medtronic Recent Developments/Updates
 Table 85. Bayer AG Company Information
 Table 86. Bayer AG Description and Business Overview
 Table 87. Bayer AG Continuous Blood Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Bayer AG Continuous Blood Glucose Monitoring Product
 Table 89. Bayer AG Recent Developments/Updates
 Table 90. Abbott Company Information
 Table 91. Abbott Description and Business Overview
 Table 92. Abbott Continuous Blood Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Abbott Continuous Blood Glucose Monitoring Product
 Table 94. Abbott Recent Developments/Updates
 Table 95. Terumo Company Information
 Table 96. Terumo Description and Business Overview
 Table 97. Terumo Continuous Blood Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Terumo Continuous Blood Glucose Monitoring Product
 Table 99. Terumo Recent Developments/Updates
 Table 100. Dexcom Company Information
 Table 101. Dexcom Description and Business Overview
 Table 102. Dexcom Continuous Blood Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Dexcom Continuous Blood Glucose Monitoring Product
 Table 104. Dexcom Recent Developments/Updates
 Table 105. Echo Therapeutics Company Information
 Table 106. Echo Therapeutics Description and Business Overview
 Table 107. Echo Therapeutics Continuous Blood Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Echo Therapeutics Continuous Blood Glucose Monitoring Product
 Table 109. Echo Therapeutics Recent Developments/Updates
 Table 110. B. Braun Melsungen Company Information
 Table 111. B. Braun Melsungen Description and Business Overview
 Table 112. B. Braun Melsungen Continuous Blood Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. B. Braun Melsungen Continuous Blood Glucose Monitoring Product
 Table 114. B. Braun Melsungen Recent Developments/Updates
 Table 115. Arkray Company Information
 Table 116. Arkray Description and Business Overview
 Table 117. Arkray Continuous Blood Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Arkray Continuous Blood Glucose Monitoring Product
 Table 119. Arkray Recent Developments/Updates
 Table 120. Cellnovo Group Company Information
 Table 121. Cellnovo Group Description and Business Overview
 Table 122. Cellnovo Group Continuous Blood Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Cellnovo Group Continuous Blood Glucose Monitoring Product
 Table 124. Cellnovo Group Recent Developments/Updates
 Table 125. Nemaura Company Information
 Table 126. Nemaura Description and Business Overview
 Table 127. Nemaura Continuous Blood Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Nemaura Continuous Blood Glucose Monitoring Product
 Table 129. Nemaura Recent Developments/Updates
 Table 130. Tandem Diabetes Care Company Information
 Table 131. Tandem Diabetes Care Description and Business Overview
 Table 132. Tandem Diabetes Care Continuous Blood Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Tandem Diabetes Care Continuous Blood Glucose Monitoring Product
 Table 134. Tandem Diabetes Care Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Continuous Blood Glucose Monitoring Distributors List
 Table 138. Continuous Blood Glucose Monitoring Customers List
 Table 139. Continuous Blood Glucose Monitoring Market Trends
 Table 140. Continuous Blood Glucose Monitoring Market Drivers
 Table 141. Continuous Blood Glucose Monitoring Market Challenges
 Table 142. Continuous Blood Glucose Monitoring Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Continuous Blood Glucose Monitoring
 Figure 2. Global Continuous Blood Glucose Monitoring Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Continuous Blood Glucose Monitoring Market Share by Type: 2024 & 2031
 Figure 4. Self-Monitoring Blood Glucose Systems Product Picture
 Figure 5. Continuous Glucose Monitoring Systems Product Picture
 Figure 6. Global Continuous Blood Glucose Monitoring Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Continuous Blood Glucose Monitoring Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Home Care
 Figure 11. Global Continuous Blood Glucose Monitoring Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Continuous Blood Glucose Monitoring Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Continuous Blood Glucose Monitoring Sales (2020-2031) & (K Units)
 Figure 14. Global Continuous Blood Glucose Monitoring Average Price (USD/Unit) & (2020-2031)
 Figure 15. Continuous Blood Glucose Monitoring Report Years Considered
 Figure 16. Continuous Blood Glucose Monitoring Sales Share by Manufacturers in 2024
 Figure 17. Global Continuous Blood Glucose Monitoring Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Continuous Blood Glucose Monitoring Players: Market Share by Revenue in Continuous Blood Glucose Monitoring in 2024
 Figure 19. Continuous Blood Glucose Monitoring Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Continuous Blood Glucose Monitoring Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Continuous Blood Glucose Monitoring Sales Market Share by Country (2020-2031)
 Figure 22. North America Continuous Blood Glucose Monitoring Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Continuous Blood Glucose Monitoring Sales Market Share by Country (2020-2031)
 Figure 26. Europe Continuous Blood Glucose Monitoring Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Continuous Blood Glucose Monitoring Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Continuous Blood Glucose Monitoring Revenue Market Share by Region (2020-2031)
 Figure 34. China Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Continuous Blood Glucose Monitoring Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Continuous Blood Glucose Monitoring Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Continuous Blood Glucose Monitoring Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Continuous Blood Glucose Monitoring Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Continuous Blood Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Continuous Blood Glucose Monitoring by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Continuous Blood Glucose Monitoring by Type (2020-2031)
 Figure 56. Global Continuous Blood Glucose Monitoring Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Continuous Blood Glucose Monitoring by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Continuous Blood Glucose Monitoring by Application (2020-2031)
 Figure 59. Global Continuous Blood Glucose Monitoring Price (USD/Unit) by Application (2020-2031)
 Figure 60. Continuous Blood Glucose Monitoring Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS